This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech Is Where the Bucks Are

NEW YORK ( TheStreet) -- Successful investors use the same strategy as successful fishermen: You put your line in the water; if you catch something, you stick around. If you don't, you go fish somewhere else.

Fisherman love gadgets and tools to help them find the fish. Sometimes fish show up where they are supposed to, sometimes not.

Fishing is not about following the gadgets, however; it's about following the fish.

It is the same with stocks. Right now, the biotech sector, for the umpteenth week in a row, continues to be the leading sector in my Best Stocks Now app.

Data from Best Stocks Now App

There are a million reasons why. But the most important reasons come not from the pundits or even the CEO. They come from the stocks themselves.

Let's look at three biotech stocks that should be in your portfolio now.

When I write about biotech companies, or talk about them in the news, I hear from investors about why this company or that stock should be doing better.

This company just received a $50 million line of credit. Or that company just hired a new technology officer. But the stock does not listen.

It goes where it wants to go.

So I follow the stocks. Two weeks ago, my Best Stocks Now app declared Regeneron (REGN - Get Report) to be my top stock, not just in biotech, but among the entire 3,300-plus stocks that I follow.

I wrote an articleabout my No. 1 stock pick at that time.

Data from Best Stocks Now App

Regeneron makes drugs for cancer and arthritis and macular degeneration. It also makes big profits for investors.

When my Best Stocks Now app made it the top pick two weeks ago, Regeneron had returned 71%, 104%, 59%, respectively, to investors over the last one, three and five years. Those are annual rates of return. Not total return!

Here is what the total returns look like now.

Data from Best Stocks Now App

This has been one of the premier growth stocks of the last 10 years. A week after I made the call, Regeneron jumped up and became the biggest-gaining stock in the market that day. And I still like it.

Data from Best Stocks Now App

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AEGR $25.91 -0.50%
GILD $100.69 -0.31%
REGN $459.78 1.16%
AAPL $126.37 2.53%
FB $83.20 -0.13%


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs